NCT06242119
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +20 more
- Locations
-
- Department of Endocrinology and Nuclear Medicine, University Hospital in Krakow Krakow, Poland
Clinical trial condition
Neuroendocrine Carcinoma
Explore clinical trials studying Neuroendocrine Carcinoma. Study availability and eligibility vary by location and protocol.
52 public trials
14 recruiting studies
Neuroendocrine Carcinoma trial results
NCT06440057
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +8 more
- Locations
-
- Chinese PLA General Hospital Beijing, Beijing Municipality, China
NCT06372626
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +8 more
- Locations
-
- Chinese PLA General Hospital Beijing, Beijing Municipality, China
NCT06369181
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +19 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
Enrolling by Invitation
RegisterNET - A Registry for Neuroendocrine Tumors in the USA and Worldwide
NCT02270567
- Conditions
- Adenocarcinoma, Carcinoid, Carcinoid Tumor, +15 more
- Locations
-
- Wren Laboratories Branford, Connecticut, United States
Not Yet Recruiting
A Study of ZG006 for Injection Versus Investigator-Selected Chemotherapy in Participants With Advanced Neuroendocrine Carcinoma
NCT07595913
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +8 more
- Locations
-
- The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
Not Yet Recruiting
A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate
NCT06941480
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +11 more
- Locations
-
- Memorial Sloan Kettering Cancer Center Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities ) Commack, New York, United States
Completed
RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma
NCT00113360
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Islet Cell, +17 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States
NCT01642251
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +23 more
- Locations
-
- Loma Linda University Medical Center Loma Linda, California, United States
- Stanford Cancer Institute Palo Alto Palo Alto, California, United States
- Rocky Mountain Cancer Centers-Aurora Aurora, Colorado, United States
- The Medical Center of Aurora Aurora, Colorado, United States
NCT04069299
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +8 more
- Locations
-
- H Lee Moffitt Cancer & Research Institute Tampa, Florida, United States